TransMedics TMDX
NASDAQ TMDX
$86.40 -1.87 (-2.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

TransMedics (TMDX) Other Operating Expenses (2023)

TransMedics (TMDX) posted Other Operating Expenses of $27.2 million for Q3 2023.

Analysis

TransMedics (TMDX) Other Operating Expenses (2023) Analysis & Trends

TransMedics has reported Other Operating Expenses for 1 years, with the latest figure at $27.2 million in Q3 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $27.2 million in Q3 2023; TTM through Jun 2024 was $27.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $27.2 million, changed N/A from the prior year.
  • Other Operating Expenses was $27.2 million for Q3 2023 at TransMedics.
  • The five-year high for Other Operating Expenses was $27.2 million in Q3 2023, with the low at $27.2 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 TransMedics 2.98 Bn 2.51 Bn 113.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 27.21 Mn